Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement
NCT07703540 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2026-07-14
Summary
This study investigates a new, simplified approach to measuring blood pressure within the liver (portal hypertension) using Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement (EUS-PPG). While this minimally invasive method traditionally relies on a hepatic vein as the baseline reference point, advanced liver scarring can make these veins twisted and highly difficult to access. To address this challenge, our study evaluates the Inferior Vena Cava (IVC)-the body's largest main vein-as an alternative reference site. Currently, it remains scientifically unproven whether the inferior vena cava or the hepatic vein provides the more reliable and accurate pressure reading for calculation, as anatomical distortion from cirrhosis can affect both areas differently. By measuring and comparing both venous compartments during a single, clinically scheduled endoscopy session, this study aims to determine if the pressures are truly interchangeable. Ultimately, this research will clarify which vessel serves as the optimal reference point, helping to establish a safer, more reliable diagnostic standard for patients with complex vascular anatomy.
Conditions
- Cirrhosis
- Liver Disease Chronic
- Portal Hypertension
Interventions
- DIAGNOSTIC_TEST
-
HVP-PPG and IVCP-PPG
During a clinically indicated endoscopic ultrasound (EUS), patients undergo portal pressure gradient (PPG) measurement using a linear-array echoendoscope and a dedicated needle system (22G or 25G). The intervention utilizes a transgastric approach to sequentially measure pressures in three vessels: a left intrahepatic portal vein branch, a hepatic vein, and the inferior vena cava (IVC). The IVC is safely punctured through a window covered by liver tissue. Pressures are measured in triplicate per vessel. This protocol uniquely calculates two distinct gradients within the same procedural session: HVP-PPG: Calculated as the mean portal vein pressure minus the mean hepatic vein pressure (HVP). IVCP-PPG: Calculated as the mean portal vein pressure minus the mean inferior vena cava pressure (IVCP).
Sponsors & Collaborators
-
University Hospital Muenster
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-01
- Primary Completion
- 2026-04-30
- Completion
- 2026-05-15
Countries
- Germany
Study Locations
More Related Trials
-
Liver Cirrhosis Complicated by Clinically Significant Portal Hypertension
NCT07365709 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Non-Invasive Portal and Hepatic Vein Pressure Estimation
NCT06210178 ·Status: RECRUITING ·Phase: NA
-
Ultrasound Prediction of Esophageal Variceal Bleeding Risk
NCT07571876 ·Status: NOT_YET_RECRUITING
-
Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis
NCT04797910 ·Status: UNKNOWN
-
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
NCT04782050 ·Status: COMPLETED ·Phase: NA
-
Prognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on Cirrhosis
NCT05800561 ·Status: UNKNOWN
-
Can MRI Evaluate Beta-blocker Response in Portal Hypertension?
NCT03114813 ·Status: UNKNOWN
-
Surrogate Markers of Portal Pressure
NCT02508298 ·Status: COMPLETED ·Phase: NA
-
EUS Share-wave in Patients With Liver Cirrhosis
NCT04644055 ·Status: COMPLETED
-
A Novel Imaging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis (CHESS2104)
NCT05068492 ·Status: NOT_YET_RECRUITING
-
Utility of EUS-elastography to Predict Portal Hypertension
NCT03155282 ·Status: COMPLETED
-
LSM and SSM for the Diagnosis of CSPH: a Prospective Cohort Study
NCT06181409 ·Status: RECRUITING
-
Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)
NCT03990753 ·Status: UNKNOWN
-
Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)
NCT07506642 ·Status: COMPLETED
-
Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension
NCT03277651 ·Status: UNKNOWN
-
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
NCT01747772 ·Status: COMPLETED ·Phase: NA
-
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
NCT01350167 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Study to Monitor Liver Diseases Dynamically by Ultrasound Viscoelasticity
NCT03777293 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.
NCT03778411 ·Status: COMPLETED
-
Efficacy of Endoscopic Ultrasound Guided Liver Biopsy Using Dynamic Wet Technique
NCT06833619 ·Status: RECRUITING ·Phase: NA
-
Two-dimensional Shear Wave Elastography for Assessment of Cirrhosis and Portal Hypertension
NCT06358092 ·Status: NOT_YET_RECRUITING
-
Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients
NCT05228509 ·Status: RECRUITING
-
Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin
NCT02994485 ·Status: COMPLETED ·Phase: PHASE4
-
Portal Hypertension Using Magnetic Resonance Elastography
NCT05749198 ·Status: COMPLETED
-
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
NCT05475015 ·Status: RECRUITING